Concepedia

Mohamed Azab

MA

Statistics

Publications

14

Citations

754

H-Index

11

Active since

1988

Affiliations

Institut Gustave Roussy(Current)

University of Nevada, Las Vegas

Mohamed Azab is an author at Institut Gustave Roussy specializing in medicine, oncology, and pharmacology.

Publications per year

1988–2021

14

Publications

14

Comparison of the 5-Hydroxytryptamine<sub>3</sub>(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis

Michel Marty, P Pouillart, Jean Pierre Droz et al. · New England Journal of Medicine · 1990 · 411 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk. Gestational trophoblastic tumors

Mohamed Azab, Jean-Pierre Droz, Christine Théodore et al. · Cancer · 1989 · 56 citations · Full text

Medicine, Oncology, Surgery +13

Phase II study of elliptinium acetate salvage treatment of advanced breast cancer

Jacques Rouëssé, M. Spielmann, F Turpin et al. · European Journal of Cancer · 1993 · 54 citations

Medicine, Oncology, Pharmacotherapy +16

Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide

Christine Théodore, Mohamed Azab, Jean‐Pierre Droz et al. · Cancer · 1989 · 52 citations · Full text

Medicine, Oncology, Pharmacology +13

Prognostic factors in gestational trophoblastic tumors. A multivariate analysis

Mohamed Azab, Christine Théodore, Jean‐Pierre Droz et al. · Cancer · 1988 · 41 citations

Medicine, Gynecology, Oncology +16

1–5 of 14